SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
XOMA. Bull or Bear?
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
17367 72 0 XOMA
Emcee:  Olu Emuleomo Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
15892I regard Cacaito as a friend and a valuable resource. He would be more valuableaknahow-7/17/2002
15891George, what do you think a guy like this will do with Neuprex???? Enjoy. busBluegreen-7/17/2002
15890Cacaito, here it is from Genentech website>>>>>>>>>&gBluegreen-7/17/2002
15889..."and never see the contingencies"... It is a reference to the Dna Cacaito-7/17/2002
15888The bottom line is that the discourse about Biogen with respect to xoma in SI, yCacaito-7/17/2002
15887Sad, sad, sad! While I recognize that DNA screwed up by not limiting the number aknahow-7/16/2002
15886I would like to kindly ask what your intent is and tell you the effect you have Lance Bredvold-7/16/2002
15885Biogen expects Amevive in the market Q402 or Q103, which have been their goal alCacaito-7/16/2002
15884Getting a complete response letter is a serious event. You were one of those whoaknahow-7/16/2002
15883Your Flumist example is perfect for Xanelim, incomplete data, clinicals, manufacCacaito-7/15/2002
15882When are they going to file? pre or post contingencies !!!Cacaito-7/15/2002
15881Mr Gw, the very cool one, who sees imclowns and elanes all over the place and neCacaito-7/15/2002
15880Are you saying that you like the idea of PFE being a competitor??? I thought yoBluegreen-7/15/2002
15879I fully understand that contingencies exist for Xanelim as they do for any prospaknahow-7/15/2002
15878Bluegreen, competition is good. Period !!!Cacaito-7/15/2002
15877Gw, you are always into details explanations, can you explained the ContingencieCacaito-7/15/2002
15876Neither has cacaito reached the cool stage of calling decent, honest, cash rich Cacaito-7/15/2002
15875Please leave Cacaito alone, he and others are suffering from hyper loss syndromeaknahow-7/14/2002
15874Cacaito, are you saying they should file even IF they had a non-positive outcomeBluegreen-7/14/2002
15873This time it comes with a "contingent" caveat: "Xanelim™ (EfalizCacaito-7/13/2002
15872xoma the imclowns with some luck, otherwise the same !!!Cacaito-7/13/2002
15871Patent Application announced 11 July 02. BPI does everything, too bad it canaknahow-7/11/2002
15870prnewswire.com Society of Critical Care Medicine to Hold Writers Workshop on Diaknahow-6/24/2002
15869Last day for Bax call. Listen now or not at all! Interesting observation. theaknahow-6/24/2002
15868Robert KK or anyone, why would any partner begin clinical trials with a drug proaknahow-6/24/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News